Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer.
about
Prescription of kampo drugs in the Japanese health care insurance programChemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspectiveTherapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral NeuropathyLifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review.Predicting acute and persistent neuropathy associated with oxaliplatin.Thujone-Rich Fraction of Thuja occidentalis Demonstrates Major Anti-Cancer Potentials: Evidences from In Vitro Studies on A375 Cells.Herbal medicines for the treatment of cancer chemotherapy-induced side effects.New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in ratsTherapeutic effects of saireito (chai-ling-tang), a traditional Japanese herbal medicine, on lymphedema caused by radiotherapy: a case series studySignificance of Kampo, traditional Japanese medicine, in supportive care of cancer patientsCan medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy?Herbal Medicine Goshajinkigan Prevents Paclitaxel-Induced Mechanical Allodynia without Impairing Antitumor Activity of Paclitaxel.Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.Efficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients.Efficacy of Japanese traditional (Kampo) medicine for treating chemotherapy-induced peripheral neuropathy: A retrospective case series study.Kampo medicine for palliative care in Japan.Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).Long-term effects of goshajinkigan in prevention of diabetic complications: a randomized open-labeled clinical trial.Emotional Responses to Persistent Chemotherapy-induced Peripheral Neuropathy Experienced by Patients with Colorectal Cancer in Japan.Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: protocol for a systematic review and meta-analysis.Safety and efficacy of calcium and magnesium infusions in the chemoprevention of oxaliplatin-induced sensory neuropathy in gastrointestinal cancers.Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.Dietary Intake of Magnesium or Calcium and Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Patients.
P2860
Q21284832-B12B826A-827F-4B60-9C56-FF6765E6601EQ26777967-6DDF2A6E-C0A8-4447-8170-277203B0A5F7Q28075341-B8505AD3-513B-4E23-852B-BF1356327D22Q30234847-9F2D40B1-438E-4525-87C1-9F6E2FF9EF4BQ33841734-509BE591-5273-4FBB-965C-0872B8C457F9Q35020922-0FAE98D5-7856-48F5-BAAF-CC2CF30C49DCQ35066654-94D5D0BB-1A6D-462A-8D6F-67F4B9483B2CQ36226275-0238FA9A-F68B-455B-8B34-694DA8DEA1D9Q36254642-8EFA64D9-B31B-47AD-8553-B58B7AEFD65FQ36942802-5B7F75C9-98DB-4F01-93BF-659D555956F4Q36990461-4126C42C-2256-4E1C-B429-1D4E3B0035D4Q37105226-03403192-7E69-4AF5-9143-8BD0A3AC41ACQ37254133-1246905B-4071-4C24-807F-FE3D871E21FFQ37325728-68DDCC7C-C118-40C7-A877-23E349D1ACB0Q37338244-E76E19DC-B02F-4244-8BB0-406B61234178Q37345334-1F81CC84-8161-4B65-8921-978F91D07F73Q37513030-A9B947F9-8826-4A68-9C01-570EA3503AEBQ37662241-5E9BFD53-173B-47E8-9B36-F91F94FF7EE9Q37725008-C2E21AAD-267A-4FE8-A440-CA5B91B1996AQ38684985-091B9E4F-9848-48B8-8AB3-5F3AC7197AA2Q39021089-F2421F7A-9BE8-4AE9-85BF-9D83247B74EAQ45837121-5FE876F0-7948-4C0A-A4B1-FD8CCE65D42BQ47767827-4EF87D99-FD76-465D-AE7A-072F534ECD26Q50590441-3B669576-4A27-4851-8214-5B0C5734F53EQ55031561-8846B660-7BD6-49A6-BC0C-5FB521A07EB3
P2860
Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy of goshajinkigan for ...... r recurrent colorectal cancer.
@ast
Efficacy of goshajinkigan for ...... r recurrent colorectal cancer.
@en
type
label
Efficacy of goshajinkigan for ...... r recurrent colorectal cancer.
@ast
Efficacy of goshajinkigan for ...... r recurrent colorectal cancer.
@en
prefLabel
Efficacy of goshajinkigan for ...... r recurrent colorectal cancer.
@ast
Efficacy of goshajinkigan for ...... r recurrent colorectal cancer.
@en
P2093
P2860
P356
P1476
Efficacy of goshajinkigan for ...... r recurrent colorectal cancer.
@en
P2093
Hirotaka Yamazaki
Jiro Watari
Kazunori Kamiya
Naoyuki Chisato
Noriaki Mamiya
Shigetaka Suzuki
Toshiyuki Asama
Yasuhiro Yamamoto
Yosiaki Ebisawa
P2860
P304
P356
10.1093/ECAM/NEP200
P577
2011-01-11T00:00:00Z